Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
de Montalembert
M
M
Centre de Transfusion, Hôpital Necker, Paris, France.
Girot
R
R
Mattlinger
B
B
Lefrère
J J
JJ
D015331:Cohort Studies; D003586:Cytomegalovirus Infections / Q000150:complications / Q000453:epidemiology / Q000635:transmission*; D006800:Deltaretrovirus Infections / Q000150:complications / Q000453:epidemiology / Q000635:transmission; D017707:Erythrocyte Transfusion / Q000009:adverse effects; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000635:transmission; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology / Q000635:transmission; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology / Q000628:therapy / Q000635:transmission; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000453:epidemiology / Q000635:transmission*; D006801:Humans; D015337:Multicenter Studies as Topic; D015995:Prevalence; D011446:Prospective Studies; D012192:Retroviridae Infections / Q000150:complications / Q000453:epidemiology / Q000635:transmission*; D013789:Thalassemia / Q000150:complications / Q000628:therapy*; D065227:Transfusion Reaction; D014481:United States / Q000453:epidemiology